The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

White Papers
The initial purpose for developing a socially responsible, closed loop supply chain was to enhance our environmentally sustainable practices by p
White Papers
This paper provides a case-study on what Banner has done to implement and continuously improve this initiative.
White Papers
A well-conceived strategic sourcing program starts with an analysis of the total spend or operating expenses of the organization utilizing an
White Papers
On August 8, 2011, the Association for Health Care Resource & Materials Management hosted an Executive Thought Leader Event, sponsored by VHA
White Papers
This paper examines the journey that an organization travels to arrive at an outsource decision and the challenges that it should be alert to
Case Studies
Overview Wellmont Health System is a leading healthcare provider in the Tri-Cities region of Northeast Tennessee a